5728-44-9

Basic information

• Product Name: 4-(2-Cyanophenyl)benzoic acid
• Synonyms: 4-(2-Cyanophenyl)benzoic acid;2'-Cyano-4-biphenylcarboxylic acid
• CAS NO: 5728-44-9
• Molecular Formula: C₁₄H₉NO₂
• Molecular Weight: 223.23
• Mol File: 5728-44-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 569.2°C at 760 mmHg
• Flash Point: 298°C
• Appearance: /
• Density: 1.622g/cm³
• Vapor Pressure: 8.55E-14mmHg at 25°C
• Refractive Index: 1.72
• CAS DataBase Reference: 4-(2-Cyanophenyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-Cyanophenyl)benzoic acid(5728-44-9)
• EPA Substance Registry System: 4-(2-Cyanophenyl)benzoic acid(5728-44-9)

Safety Data

• Hazardous Substances Data: 5728-44-9(Hazardous Substances Data)

Usage

Description

4-(2-Cyanophenyl)benzoic acid is a chemical compound with the molecular formula C15H11NO2, belonging to the benzoic acid derivatives and featuring a cyanophenyl group. This versatile chemical is characterized by its structural properties and functional groups, making it a valuable building block in organic synthesis and medicinal chemistry for the development of pharmaceutical drugs and other organic compounds.

Uses

Used in Pharmaceutical Industry:
4-(2-Cyanophenyl)benzoic acid is used as a key intermediate in the synthesis of pharmaceutical drugs, leveraging its structural properties and functional groups to contribute to the development of new medications.
Used in Medicinal Chemistry:
4-(2-Cyanophenyl)benzoic acid is utilized as a building block in medicinal chemistry for the creation of compounds with potential therapeutic applications, particularly in the areas of anti-inflammatory and anti-cancer drugs.
Used in Organic Synthesis:
4-(2-Cyanophenyl)benzoic acid serves as a versatile component in organic synthesis, enabling the production of a wide range of organic compounds for various applications.
Used as a Fluorescent Probe in Analytical Chemistry:
4-(2-Cyanophenyl)benzoic acid has demonstrated potential as a fluorescent probe, making it useful for the detection and analysis of biologically relevant analytes, thus contributing to advancements in analytical chemistry and related fields.

InChI:InChI=1/C12H15NO6/c14-8-5-19-11(10(16)9(8)15)13-7-3-1-6(2-4-7)12(17)18/h1-4,8-11,13-16H,5H2,(H,17,18)/t8-,9+,10-,11+/m1/s1

Upstream product

• 2042-37-7 o-cyanobromobenzene 
• 14047-29-1 4-carboxyphenylboronic acid 
• 3808-91-1 4-acetyl-2'-bromobiphenyl 
• 2052-07-5 2-Bromobiphenyl 
• 3808-94-4 2'-bromobiphenyl-4-carboxylic acid 
• 544-92-3 copper(I) cyanide 
• 89900-98-1 methyl 2'-cyano-[1,1'-biphenyl]-4-carboxylate 

Downstream Products

• 89900-98-1 methyl 2'-cyano-[1,1'-biphenyl]-4-carboxylate 
• 679407-02-4 2'-cyano-biphenyl-4-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-phenyl]-amide 

Relevant articles and documents

PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERSAS AS AGONISTS OF G- PROTEIN COUPLED RECEPTOR 43 (GPR43)

The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs

Anthranilamides 4 and 5 were designed and synthesized as selective and orally bioavailable factor Xa inhibitors. Structural modifications aimed at lowering their lipophilicity were performed at the central phenyl ring and at the S4 binding biphenyl region by incorporating water solublizing substituents. The resulting compounds (e.g., 7, 8, 14, 30a, and 32b) are highly potent in vitro, and show improved activity in human plasma-based thrombin generation assay.

PIPERAZINE AND HOMOPIPERAZINE COMPOUNDS

Compounds are provided having a piperazine or homopiperazine ring which are useful in the treatment of thrombosis.